본문으로 건너뛰기
← 뒤로

Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.

1/5 보강
Heliyon 📖 저널 OA 100% 2021: 1/1 OA 2022: 5/5 OA 2023: 21/21 OA 2024: 91/91 OA 2025: 28/28 OA 2021~2025 2024 Vol.10(13) p. e34032
Retraction 확인
출처

Xiong X, Huang B, Gan Z, Liu W, Xie Y, Zhong J, Zeng X

📝 환자 설명용 한 줄

Thyroid cancer is the most common malignant tumor of the endocrine system, and evidence suggests that post-translational modifications (PTMs) and epigenetic alterations play an important role in its d

이 논문을 인용하기

↓ .bib ↓ .ris
APA Xiong X, Huang B, et al. (2024). Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.. Heliyon, 10(13), e34032. https://doi.org/10.1016/j.heliyon.2024.e34032
MLA Xiong X, et al.. "Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.." Heliyon, vol. 10, no. 13, 2024, pp. e34032.
PMID 39091932 ↗

Abstract

Thyroid cancer is the most common malignant tumor of the endocrine system, and evidence suggests that post-translational modifications (PTMs) and epigenetic alterations play an important role in its development. Recently, there has been increasing evidence linking dysregulation of ubiquitinating enzymes and deubiquitinases with thyroid cancer. This review aims to summarize our current understanding of the role of ubiquitination-modifying enzymes in thyroid cancer, including their regulation of oncogenic pathways and oncogenic proteins. The role of ubiquitination-modifying enzymes in thyroid cancer development and progression requires further study, which will provide new insights into thyroid cancer prevention, treatment and the development of novel agents.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기